Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - treatment with an aldose reductase inhibitor
Toru Tsugawa(Fujita Health University), M. Itoh(Fujita Health University), Fumikazu Takeda(Saitama Cancer Center), Akio Nagasaka(Fujita Health University), M. Nagata(Fujita Health University), Aya Suzuki(Fujita Health University), Rikio Shinohara(Fujita Health University), Y Sawai(Fujita Health University), Naohiro Hayakawa(Fujita Health University), Itsuko Nakano(Fujita Health University), Naohisa Oda(Fujita Health University)
Cited by 12
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with Lung Cancer
|European Journal of Cancer|1998|255
A Brief Cancer Pain Assessment Tool in Japanese
|Journal of Pain and Symptom Management|1998|197
Transcriptome-based systematic identification of extracellular matrix proteins
|Proceedings of the National Academy of Sciences|2008|152
Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity
|Journal of Biological Chemistry|2010|64